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Integron-associated resistance genes among multidrug-resistant
Pseudomonas aeruginosa isolated from clinical specimens
Fatma BUDAK1, Murat KASAP2, Fetiye KOLAYLI1, Aynur KARADENİZLİ1, Mustafa Haluk VAHABOĞLU3

Aim: To characterize common beta-lactamase genes and the role of integrons in beta-lactam antibiotic resistance among
multidrug-resistant (MDR) P. aeruginosa strains isolated from intensive care units in Turkey.
Materials and methods: After the examination of 67 P. aeruginosa isolates, 14 were found to be resistant to all of the
tested beta-lactams and aminoglycosides. These 14 strains were studied to characterize the beta-lactamases and related
integrons. Evaluation of minimum inhibitory concentrations, polymerase chain reaction (PCR) screening, isoelectric
focusing, outer membrane isolation and analysis, and cloning and sequencing were performed according to published
protocols.
Results: PCR screening for common beta-lactamases detected PER-1 and OXA-10 among the selected MDR P.
aeruginosa. PCR screening results showed that 2 of the isolates had 5’-3’ class I integrons. Sequence analysis of the
integrons revealed the existence of 6’-N-acetyltransferase (aac(6)-Ib) and streptomycin 3’-adenyl transferase (aadA2)
cassettes (GenBank accession no. EF368053). Coexistence of PER-1 and OXA-2 and of PER-1 and OXA-10 was
demonstrated in 8 and 7 of the isolates, respectively, by PCR. Shotgun cloning and PCR screening with relevant primers
revealed the existence of a class I integron-associated blaOXA-2 gene cassette in 2 of the isolates. Strains positive for
OXA-2 were also positive for PER-1.
Conclusion: This study demonstrated the coexistence of PER-1 and OXA-2 in a single host. Coexistence of PER-1 with
OXA-2 may increase the risk of the spreading of MDR P. aeruginosa in Turkish hospitals.
Key words: Integron, resistance genes, multidrug resistance, outer membrane protein, Pseudomonas aeruginosa

Klinik örneklerden soyutlanan, çoklu ilaç dirençli Pseudomonas aeruginosa
suşlarında integronla ilişkili direnç genleri
Amaç: Bu çalışmada, Türkiye’de çoğul dirençli P. aeruginosa suşlarında beta laktam antibiyotik direncini kodlayan
integronların tanımlanmasını amaçladık.
Yöntem ve gereç: Altmış yedi adet P. aeruginosa suşunun incelemesi sonrasında 14 tanesi tüm test edilen beta laktamazlara
ve aminoglikozidlere dirençli bulunmuştur. Bu 14 suşun beta laktamazları çalışılmış ve integronla ilişkilendirilmiştir.
Minimum inhibisyon konsantrasyonu, polimeraz zincir tepkimesi (PZT) taraması, izoelektrik odaklama, dış membran
eldesi ve analizi, klonlama ve dizileme çalışmaları yayınlanmış protokollere göre yapılmıştır.
Bulgular: Seçilmiş çoklu ilaç dirençli P. aeruginosa’lar arasında beta laktamaz için PZT taramasında PER-1 ve OXA-10
tanımlanmıştır. Tüm suşlarda yapılan PZT ile iki suş 5’-3’sınıf I integron pozitif bulunmuştur. Bu integronların sekans
analizi ile 6’-N-asetiltransferaz (aac(6)-Ib) ve streptomisin 3’-adenil transferaz (aadA2) kaseti (GenBank no. EF368053)
varlığını göstermiştir. Sekiz suş PZT ile PER-1 ile OXA-2; 7 suş ise PER-1 ve OXA-10 pozitif bulunmuştur. Shotgun
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klonlama ve uygun primerler ile PZT taraması sonucu 2 suşun sınıf I integronun varlığının blaOXA-2 gen kaseti ile
ilişkili olduğu gösterilmiştir. OXA-2 pozitif suşların hepsi PER-1 için de pozitifdir.
Sonuç: Bu çalışma tek bir konakta, PER-1 ve OXA-2’nin birlikte varlığını göstermiştir. PER-1 ve OXA-2’nin birlikte
varlığı, Türkiye’deki hastanelerde çoklu ilaç dirençli P. aeruginosa yayılma riskini arttırabilir.
Anahtar sözcükler: İntegron, direnç genleri, çoklu ilaç direnci, dış membran proteini, Pseudomonas aeruginosa

Introduction
Pseudomonas aeruginosa is a significant pathogen
leading to severe infections in hospitals. Acquisition
of multidrug resistance by P. aeruginosa is becoming
a matter of concern in many hospitals worldwide
(1,2). The increasing use of antibiotics and growing
numbers of invasive procedures, together with the
development of intrinsic and acquired resistance
mechanisms of P. aeruginosa, cause the evolution of
numerous multidrug-resistant (MDR) P. aeruginosa
outbreaks in clinical settings.
Extended-spectrum beta-lactamases (ESBLs)
that can confer resistance to cephalosporins are
common in Enterobacteriaceae and have spread
worldwide. Various class A ESBLs, such as TEM-,
SHV-, VEB-, and PER-type ESBLs, and class D ESBLs
such as OXA-type ESBLs have been identified in P.
aeruginosa (3,4).

mechanisms, including loss of the OprD porin,
overexpression of efflux systems (MexAB-OprM,
MexEF-OprN), and production of carbapenemase
activity (11). The most frequent causes of OprD
mutational inactivation were frameshift mutations
produced by insertion, deletions, and point
mutations, leading to the creation of premature stop
codons occurring in numerous isolates (12). These
genetic events were located on the whole OprD gene.
In this study, we aimed to characterize common
beta-lactamase genes and the role of integrons in
beta-lactam antibiotic resistance among MDR P.
aeruginosa strains isolated from intensive care units
in Turkey.
Material and methods
Bacterial strains

Integrons are genetic elements encoding the
components of a site-specific recombination system
that recognizes mobile gene cassettes, mostly
resistance determinants (5). It is potentially a major
agent in the dissemination of multidrug resistance
among gram-negative bacteria and Pseudomonas
(6,7). Class I integrons are predominant among
integrons that carry resistance cassettes (8) and
have a threatening potential for the development of
antimicrobial resistance and the emergence of MDR
profiles in clinical bacteria (9). Several resistance
gene cassettes are associated with class I integrons in
P. aeruginosa that confer resistance to antimicrobial
agents (10). Typically, a class I integron is composed
of a 5’-conserved segment (5’CS) including the
integrase gene (intI), and a 3’-conserved segment
(3’CS) encoding resistance to sulfonamides and
disinfectants.

A total of 67 P. aeruginosa specimens were
isolated from 6 different university hospitals’
surgery intensive care units during the years of
2000 and 2002. The hospitals were located in
various regions of Turkey, including Kayseri Erciyes
Medical Faculty, İzmir Dokuz Eylül Medical Faculty,
Trabzon Karadeniz Technical University Medical
Faculty, Samsun Ondokuz Mayıs University Medical
Faculty, İstanbul Çapa Medical Faculty, and İstanbul
Cerrahpaşa Medical Faculty. Bacteria were isolated
from clinically important sites including 8 wounds,
23 urine samples, 5 tracheal aspirates, 13 sputum
samples, and 18 catheters. All isolates were identified
by conventional methods (13) and a single isolate per
patient was retained in the study. Identifications were
confirmed using a Vitek 2 GN card (bioMerieux,
France). The 80% glycerol stocks of all isolates were
stored at –70 °C until studied.

Previous studies of clinical isolates of P. aeruginosa
reported that acquired resistance to carbapenems
resulted from the complex interaction of several

Antimicrobial susceptibility test
In order to easily determine the minimum inhibitory
concentration (MIC) values of different test agents
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for a large number of bacteria, the agar dilution
method was used with Mueller-Hinton agar (Oxoid,
Basingstoke, UK) and an inoculum of 104 colonyforming units per spot as recommended by the
Clinical and Laboratory Standards Institute (formerly
NCCLS) (14). Endpoints were read after 18 h of
incubation at 37 °C. P. aeruginosa ATCC 25983 was
used as the control strain.
Antimicrobial agents whose sources and ranges
were tested were amikacin (Eczacıbaşı; 0.125-512
μg/L), ceftazidime (GlaxoSmithKline; 0.25-1024
μg/L), cefepime (Bristol-Myers Squibb; 0.12512 μg/L), ciprofloxacin (Bayer; 0.12-512 μg/L),
imipenem (Merck; 0.064-128 μg/L), meropenem
(Astra Zeneca; 0.064-128 μg/L), piperacillin (Wyeth;
0.25-512 μg/L), piperacillin/tazobactam (0.25-128
μg/L), and cefoperazone/sulbactam (1-256 μg/L).
Experiments were repeated 3 times and the results
were evaluated together.
Polymerase chain reaction experiments
A loopful of bacteria was suspended in 100 μL of
double distilled water. The bacterial extract containing
the DNA was obtained by incubating bacterial
suspensions at 95 °C for 10 min and sedimenting
the debris for 10 min at 12,000 × g. The supernatant
was stored at –20 °C until use. Polymerase chain
reaction (PCR) screenings were accomplished in a
final volume of 50 μL with 5 μL of DNA extract. The
master mixture was composed of 1× buffer supplied
with DNA Taq polymerase (Fermentas, Lithuania),
1.5 mM MgCl2, 0.2 mM dNTPs, 50 pmol of each
primer, and 1.5 U of Taq polymerase. Amplification

was accomplished after 5 min of initial denaturation
at 94 °C with 40 cycles of 1 min of denaturation at 94
°C, 1 min of annealing at an appropriate annealing
temperature (9,15-17), and 90 s of elongation at 72
°C. The annealing temperature for each primer set
is given in Table 1. PCR products were examined
on a 1.5% agarose gel at a constant 12 V/cm and
visualized using an image analysis system (SciGene,
UK). The sequence analyses were accomplished
after product purification using the High Pure PCR
Product Purification Kit (Roche Diagnostics, Basel,
Switzerland). The sequencing was performed at
İontek, Inc. (İstanbul, Turkey).
Sequence data were read and edited with either
ChromasPro (http://www.technelysium.com.au) or
BioEdit version 7.0.5.2.
Isoelectric focusing
For isoelectric focusing (IEF), crude cell extracts
were prepared by sonication. IEF was performed on
5% polyacrylamide gels containing ampholytes (pH
range of 3-10; Fluka, Switzerland) with a Model 111
Mini IEF Cell (Bio-Rad Laboratories, USA) (18).
Enzymes were focused at a constant 1 W for 45
min and detected by overlaying the gel with 1 mM
nitrocefin solution. Known enzymes SHV-1 (pI 7.6),
OXA-14 (pI 6.2), and TEM-1 (pI 5.4) were used as
standards (19).
Isolation of outer membrane proteins
Outer membrane proteins were isolated
according to a published procedure (20). Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis

Table 1. Primers used for PCR screening.

5’-3’ nucleotide sequence

Annealing temp.
(°C)

References

5’CS-GGC ATC CAA GCA GCA AG
3’CS-AAG CAG ACT TGA CCT GA

58.5

9

F(5-’AAT TTG GGC TTA GGG CAG AA-3’)
R(5-’ ATG AAT GTC ATT ATA AAA GC-3’)

52

15

OXA-10

F (5’-TCT TTC GAG TAC GGC ATT AGC-3’)
R(5’-CCA ATG ATG CCC TCA CTT TCC-3’)

51

16

OXA-2

F(5-’GCC AAA GGC ACG ATA GTT GT-3’)
R(5-’GCG TCC GAG TTG ACT GCC GG-3’)

51.5

17

Primers
Integron I
PER-1
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(SDS-PAGE) was performed using the procedure of
Laemmli (21) and the gels (12%) were stained with
Coomassie blue before analysis. OprD-positive (PT5)
and OprD-negative (PT149) standard strains, kindly
provided by T. Kohler in 1997, were used.

Results
Antimicrobial susceptibility test
Among the 67 isolates, 53 isolates were susceptible
to all antimicrobial agents tested. It was found that
14 of them isolated from 6 different intensive care
units locations were resistant to all of the tested betalactams and aminoglycosides (Table 2).

Shotgun cloning
Shotgun cloning was used to hunt and
clone beta-lactamases and related integrons for
genetic characterization from genomic DNA.
For shotgun cloning, genomic DNA of isolate
13 was partially digested with MboI and ligated
to the dephosphorylated BamHI arms of pZerO
(Stratagene, USA) overnight at 16 °C, then
transformed to electrocompetent E. coli DH10B cells
(Invitrogen, USA) by electroporation at 1700 V in a
50-μL volume. Positive clones were selected on agar
plates supplemented with ampicillin (50 μg/mL) and
Zeocin (50 μg/mL) (22). The insert’s sequence was
determined by the dye-terminator cycle sequencing
method using universal T3 and T7 primers (İontek,
Inc.). When necessary, new sequencing primers were
synthesized by İontek and used for DNA walking.

PCR experiments
Integron screening of these 14 isolates by PCR
revealed 2 integron-positive strains. PCR products
from the positive strains were sequenced and
revealed a single sequence identity (GenBank
accession no. EF368053). In addition, PER-1 and
OXA-10 PCR screening of 14 isolates revealed the
presence of 8 blaPER-1-positive and 8 blaOXA-10-positive
strains. Furthermore, by PCR, 8 isolates had PER-1
and OXA-2, and 7 isolates had PER-1 and OXA-10
(Table 3).
Isoelectric focusing
Isoelectric focusing of the 14 isolates indicated
the presence of 2 bands in some experiments at
around pI 8.6 and in the others at 7.6, in addition to
PER-1 and OXA-10 bands (Figure 1). Cloning and
sequencing efforts allowed us to identify these bands
as OXA-2, which was expected to give a single band
of pI 6.8.

Cloning of PCR products
The PCR products were cloned into a pCR2.1TOPO vector according to the instructions of
the manufacturer of the TOPO TA Cloning Kit
(Invitrogen).

Table 2. MIC (μg/mL) values of 14 MDR isolates.
No.

IMP

MEM

CAZ

CEF

CIP

AK

PIP/TAZO

PIP

CEF/SUL

1
2
3
4
5
6
7
8
9
10
11
12
13
14

32
32
16
64
32
32
64
16
32
32
32
64
32
32

32
16
32
32
16
16
64
16
32
16
16
32
32
32

256
512
256
16
512
512
256
128
512
512
512
512
512
512

128
128
64
16
128
64
128
64
64
64
128
512
16
512

1
1
64
32
4
0.5
>64
64
32
2
8
16
0.5
2

16
32
16
8
32
32
32
8
512
32
16
32
16
32

64
32
64
64
64
32
128
32
128
32
128
64
32
64

32
32
64
64
64
64
128
32
128
16
256
256
128
128

64
64
64
64
64
32
128
64
128
64
128
128
32
128

IMP, imipenem; MEM, meropenem; CAZ, ceftazidime; CEF, cefepime; CIP, ciprofloxacin; AK, amikacin; PIP/TAZO,
piperacillin/tazobactam; PIP, piperacillin; CEF/SUL, cefoperazone/sulbactam.
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Table 3. Integron PCR and resistance genes of 14 MDR isolates.
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14

Int/PCR

PER

OXA-10

OprD

Pos
Pos

Pos
Pos
Pos

Neg
Neg

Pos
Pos
Pos
Pos

Pos
Pos
Pos

Pos

Pos

OXA-2
Pos

Neg
Neg
Neg
Neg
Neg

Pos
Pos
Pos
Pos
Pos

Neg

M

Pos
Pos

Pos
Pos

1

2

Neg

Pos
Pos

pI

7.6
6.4

5.4

Figure 1. IEF bands of isolates positive for PER-1 (pI 5.3) and
OXA-2 (pI 8.6).

Isolation of outer membrane proteins
Since OprD expression is related to the acquired
antibiotic resistance, we intended to look for the
expression of OprD in the 14 isolates mentioned
above. Detailed analysis of SDS-PAGE results with
Image J indicated that, except for isolate 12, all other
studied strains lacked OprD expression (Figure 2).
Outer membrane protein isolation and examination
revealed the presence of D2 porin, while 13 of the 14
isolates lacked D2 porin protein and were MDR.

Shotgun cloning
Among the isolates with a pI value of 8.6, isolate
13 was randomly selected for shotgun cloning. A
4402-bp fragment carrying the gene for an enzyme
of pI 8.6 was cloned. The sequence analysis revealed
the presence of the blaOXA-2 gene in a type I integron.
The antibiotic resistance profile of this clone was
then compared with isolate 13 (Table 4). The clone
displayed a similar profile to that of isolate 13.
Discussion
The emergence of ESBL-producing gramnegative clinical pathogens poses a severe challenge
to antimicrobial chemotherapy, with an increasing
number of reports worldwide (23,24). Integrons and
transposons have been detected repeatedly in MDR
P. aeruginosa isolates. In this study, we aimed to
determine the rate of multidrug resistance to several
antimicrobial agents in P. aeruginosa isolated from 6
different intensive care units, with special emphasis
on ESBLs.
According to this study, 14 isolates out of 67 that
were isolated from 6 different intensive care units
displayed a resistance against beta-lactams and
aminoglycosides. PCR screening for common betalactamases detected PER-1 and OXA-10 among
these 14 MDR P. aeruginosa, and 8 of 14 MDR P.
aeruginosa strains were found to be positive for PER1. This indicated that the PER-1 promoter is active in
P. aeruginosa, as previously observed (25,26). In our
study, 7 of 14 beta-lactamase- and aminoglycosideresistant P. aeruginosa strains were found to be both
OXA-2- and OXA-10-positive, in addition to PER1. OXA-10, OXA-11, and OXA-14, which have
extended spectra, were previously identified in P.
aeruginosa isolated from a hospital in Turkey (27,28).
In this study, we showed that 8 isolates had narrowspectrum OXA-10 activity.
It was seen that 2 isolates gave a PCR product
with a 5’-3’ class I integron PCR. Sequence analysis
of these integrons revealed the existence of
6’-N-acetyltransferase (aac(6)-Ib) and streptomycin
3’-adenyl transferase (aadA2) cassettes (GenBank
accession no. EF368053). Characterization of
resistance gene cassettes associated with class I
integrons in MDR clinical isolates is of considerable
153
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M

1

2

3

4

5

M

6

7

8

9

10

11

12

13

14

15

16

17

Figure 2. Outer membrane proteins. M: protein markers; 1-3: standard strains (1: OprD-positive, 2 and 3: OprD-negative); 4-16: study
strains; 17: pure OprD protein.

Table 4. MIC values of antimicrobials for isolate 13 and clone
13, with and without clavulanic acid.
Clavulanate
neg/pos
Isolate 13
Ceftazidime
Cefepime
Pip/Tazo
Cefotaxime
Imipenem
Meropenem

256
64
16
256
32
32

16
8
<1
64
32
16

Clone 13
32
1
16
0.5
1
0.0125

1
1
<1
0.5
1
0.0125

significance (29). Class I integrons, inducing
resistance to antibiotics, play an important role in
the development of antimicrobial resistance and
emergence of MDR strains for 3 reasons. First, the
integron-mediated circular gene cassette capturing
system inserts resistance gene cassettes at the specific
attI site downstream of class I integrons with the help
of the integrase enzyme (30). Second, gene cassette
arrays have only one promoter Pc, which strongly
expresses antibiotic resistance genes, causing crossresistance (9). Third, integrons associated with
transferable plasmids and transposons widely diffuse
among bacteria and develop antibiotic resistance (31).
Another reason for carbapenem resistance is the
absence of the D2 porin protein (32,33). The main
mechanism of imipenem resistance in P. aeruginosa
is the repression or inactivation of the OprD gene
154

encoding the OprD porin. P. aeruginosa mutants
with high MICs for imipenem are easily produced in
vitro or in vivo and are often found in patients during
treatment with imipenem (34). Although OprD could
be regulated by multiple systems, the downregulation
of the porin gene alone is sufficient to induce highlevel imipenem resistance, as shown for 13 isolates.
Shotgun cloning from 1 isolate and PCR screening
with OXA-2 primers revealed the existence of a
class I integron-associated blaOXA-2 gene cassette in 2
isolates. OXA-2-positive isolates were also positive
for PER-1. A multicenter study reported ceftazidime
resistance in 28% of P. aeruginosa isolates, with
PER-1-type beta-lactamases being found in 38% of
the ceftazidime-resistant isolates (35). The results of
the present study show that isolates of P. aeruginosa
producing PER-1 and OXA-10 beta-lactamases are
encountered frequently in Turkish hospitals, and that
their clonal diversity and high prevalence indicate
a considerable potential for spread among patients
(36).
The pattern determined in the IEF of isolate 13
appeared to indicate the presence of 2 enzymes in
some experiments with pI values of 8.6 and others
of 7.6. However, the pattern seems to be a misleading
one, as the recombinant clone that possesses a class I
integron cassette harboring the blaOXA-2 gene displayed
a similar pattern. A similar phenomenon was also
reported by Holland et al. (37) and interpreted as
satellite bands.
Different from other OXA enzymes, OXA-2
hydrolyzes ceftazidime and cefotaxime and was

F. BUDAK, M. KASAP, F. KOLAYLI, A. KARADENİZLİ, M. H. VAHABOĞLU

inhibited by clavulanate (37). The OXA-2 of this
study also hydrolyzed imipenem, but weakly. In
another study, similar hydrolyzing properties were
reported for OXA-2, which provided resistant to
ceftazidime and cefotaxime and was influenced by
imipenem weakly (38).
This is the first study in Turkey that reports
the isolation of OXA-2 from 8 of 14 strains (57%
frequency). Although there was a weak imipenem
hydrolysis by OXA-2, we believe that this hydrolysis
did not contribute much to imipenem resistance.
There must be another mechanism responsible for
carbapenem resistance, as well. In this study and in a
study in Poland in 2007, PER-1 and OXA-2 enzymes
coexisted in the same isolates (39).
Integrons are natural expression vectors that
permit the insertion of antibiotic resistance genes
by a site-specific recombinational mechanism. By
using molecular techniques, we have determined
the content and order of the antibiotic resistance
gene inserted between the conserved segments in
the integrons of resistant clinical P. aeruginosa. PCR
mapping of genes inserted as cassettes into integrons
will provide valuable information for studies of gene
expression as it relates to the position of these genes
within the integrons. It is possible that the 59-base
element, a potential stem-loop-forming structure

found at the downstream end of each inserted gene
cassette, may act as an inefficient terminator of
transcription, resulting in diminished expression
of a gene inserted in the second, third, and further
positions in an antibiotic resistance operon. The
present study demonstrated the coexistence of PER1 and OXA-2 in a single host. Coexistence of PER-1
with OXA-2 may increase the risk of the spreading of
MDR P. aeruginosa in Turkish hospitals.
Conclusion
The ability of multigene antibiotic-resistant
mutants of P. aeruginosa to cause extensive outbreaks
is associated with significant morbidity and mortality.
Our findings showed the need to differentiate
polyclonal emergence of MDR P. aeruginosa from
clonal outbreaks, which require targeted infection
control measures.
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